Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 571

1.

Study of Potential Anti-Inflammatory Effects of Red Wine Extract and Resveratrol through a Modulation of Interleukin-1-Beta in Macrophages.

Chalons P, Amor S, Courtaut F, Cantos-Villar E, Richard T, Auger C, Chabert P, Schni-Kerth V, Aires V, Delmas D.

Nutrients. 2018 Dec 1;10(12). pii: E1856. doi: 10.3390/nu10121856.

2.

RAS status and neoadjuvant chemotherapy impact CD8+ cells and tumor HLA class I expression in liver metastatic colorectal cancer.

Ledys F, Klopfenstein Q, Truntzer C, Arnould L, Vincent J, Bengrine L, Remark R, Boidot R, Ladoire S, Ghiringhelli F, Derangere V.

J Immunother Cancer. 2018 Nov 19;6(1):123. doi: 10.1186/s40425-018-0438-3.

3.

Polyphenol Extracts from Red Wine and Grapevine: Potential Effects on Cancers.

Amor S, Châlons P, Aires V, Delmas D.

Diseases. 2018 Nov 18;6(4). pii: E106. doi: 10.3390/diseases6040106. Review.

4.

Indications and Outcomes of a Cross-Linked Porcine Dermal Collagen Mesh (Permacol) for Complex Abdominal Wall Reconstruction: A Multicenter Audit.

Doussot A, Abo-Alhassan F, Derbal S, Fournel I, Kasereka-Kisenge F, Codjia T, Khalil H, Dubuisson V, Najah H, Laurent A, Romain B, Barrat C, Trésallet C, Mathonnet M, Ortega-Deballon P.

World J Surg. 2018 Nov 13. doi: 10.1007/s00268-018-4853-x. [Epub ahead of print]

PMID:
30426186
5.

Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.

Bennouna J, Hiret S, Bertaut A, Bouché O, Deplanque G, Borel C, François E, Conroy T, Ghiringhelli F, des Guetz G, Seitz JF, Artru P, Hebbar M, Stanbury T, Denis MG, Adenis A, Borg C.

JAMA Oncol. 2018 Oct 25. doi: 10.1001/jamaoncol.2018.4465. [Epub ahead of print]

PMID:
30422156
6.

Total or partial removal of infected mesh? Invited comment.

Ortega-Deballon P.

Hernia. 2018 Dec;22(6):951-952. doi: 10.1007/s10029-018-1842-9. Epub 2018 Nov 7. No abstract available.

PMID:
30406323
7.

Prognostic and predictive role of CD8 and PD-L1 determination in lung tumor tissue of patients under anti-PD-1 therapy.

Fumet JD, Richard C, Ledys F, Klopfenstein Q, Joubert P, Routy B, Truntzer C, Gagné A, Hamel MA, Guimaraes CF, Coudert B, Arnould L, Favier L, Lagrange A, Ladoire S, Saintigny P, Ortiz-Cuaran S, Perol M, Foucher P, Hofman P, Ilie M, Chevrier S, Boidot R, Derangere V, Ghiringhelli F.

Br J Cancer. 2018 Oct;119(8):950-960. doi: 10.1038/s41416-018-0220-9. Epub 2018 Oct 15.

PMID:
30318514
8.

Bevacizumab-based Chemotherapy for Poorly-differentiated Neuroendocrine Tumors.

Collot T, Fumet JD, Klopfenstein Q, Vincent J, Bengrine L, Ghiringhelli F.

Anticancer Res. 2018 Oct;38(10):5963-5968. doi: 10.21873/anticanres.12943.

PMID:
30275226
9.

A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

Brandes AA, Gil-Gil M, Saran F, Carpentier AF, Nowak AK, Mason W, Zagonel V, Dubois F, Finocchiaro G, Fountzilas G, Cernea DM, Chinot O, Anghel R, Ghiringhelli F, Beauchesne P, Lombardi G, Franceschi E, Makrutzki M, Mpofu C, Urban HJ, Pichler J.

Oncologist. 2018 Sep 28. pii: theoncologist.2018-0290. doi: 10.1634/theoncologist.2018-0290. [Epub ahead of print]

PMID:
30266892
10.

Cost of complex abdominal wall reconstruction with biological prostheses in a French public hospital.

Law-Ki C, Robineau C, Garnier N, Guenfoudi MP, Lazzarotti A, Cheynel N, Cailliod R, Ortega-Deballon P.

J Visc Surg. 2018 Oct;155(5):349-353. doi: 10.1016/j.jviscsurg.2018.08.001. Epub 2018 Sep 25.

PMID:
30266341
11.

Transcriptional Programs Underlying Cd4 T Cell Differentiation and Functions.

Chalmin F, Humblin E, Ghiringhelli F, Végran F.

Int Rev Cell Mol Biol. 2018;341:1-61. doi: 10.1016/bs.ircmb.2018.07.002. Epub 2018 Aug 20.

PMID:
30262030
12.

FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer.

Carola C, Ghiringhelli F, Kim S, André T, Barlet J, Bengrine-Lefevre L, Marijon H, Garcia-Larnicol ML, Borg C, Dainese L, Steuer N, Richa H, Benetkiewicz M, Larsen AK, de Gramont A, Chibaudel B.

World J Clin Oncol. 2018 Sep 14;9(5):110-118. doi: 10.5306/wjco.v9.i5.110.

13.

LPCAT2 controls chemoresistance in colorectal cancer.

Cotte AK, Aires V, Ghiringhelli F, Delmas D.

Mol Cell Oncol. 2018 Apr 11;5(3):e1448245. doi: 10.1080/23723556.2018.1448245. eCollection 2018.

PMID:
30250902
14.

Orosensory Detection of Dietary Fatty Acids Is Altered in CB₁R-/- Mice.

Brissard L, Leemput J, Hichami A, Passilly-Degrace P, Maquart G, Demizieux L, Degrace P, Khan NA.

Nutrients. 2018 Sep 21;10(10). pii: E1347. doi: 10.3390/nu10101347.

15.

Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study.

Isambert N, Hervieu A, Rébé C, Hennequin A, Borg C, Zanetta S, Chevriaux A, Richard C, Derangère V, Limagne E, Blanc J, Bertaut A, Ghiringhelli F.

Oncoimmunology. 2018 Aug 1;7(9):e1474319. doi: 10.1080/2162402X.2018.1474319. eCollection 2018.

16.

Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.

Delanne J, Nambot S, Chassagne A, Putois O, Pelissier A, Peyron C, Gautier E, Thevenon J, Cretin E, Bruel AL, Goussot V, Ghiringhelli F, Boidot R, Tran Mau-Them F, Philippe C, Vitobello A, Demougeot L, Vernin C, Lapointe AS, Bardou M, Luu M, Binquet C, Lejeune C, Joly L, Juif C, Baurand A, Sawka C, Bertolone G, Duffourd Y, Sanlaville D, Pujol P, Geneviève D, Houdayer F, Thauvin-Robinet C, Faivre L.

Eur J Med Genet. 2018 Aug 28. pii: S1769-7212(18)30122-8. doi: 10.1016/j.ejmg.2018.08.010. [Epub ahead of print] Review.

PMID:
30165243
17.

Exome analysis reveals genomic markers associated with better efficacy of nivolumab in lung cancer patients.

Richard C, Fumet JD, Chevrier S, Derangère V, Ledys F, Lagrange A, Favier L, Coudert B, Arnould L, Truntzer C, Boidot R, Ghiringhelli F.

Clin Cancer Res. 2018 Aug 28. pii: clincanres.1940.2018. doi: 10.1158/1078-0432.CCR-18-1940. [Epub ahead of print]

PMID:
30154227
18.

CA 19-9 predicts resectability of pancreatic cancer even in jaundiced patients.

Santucci N, Facy O, Ortega-Deballon P, Lequeu JB, Rat P, Rat P.

Pancreatology. 2018 Sep;18(6):666-670. doi: 10.1016/j.pan.2018.07.001. Epub 2018 Jul 3.

PMID:
30153902
19.

Altered distribution and function of splenic innate lymphoid cells in adult chronic immune thrombocytopenia.

Audia S, Moulinet T, Ciudad-Bonté M, Samson M, Facy O, Ortega-Deballon P, Saas P, Bonnotte B.

J Autoimmun. 2018 Sep;93:139-144. doi: 10.1016/j.jaut.2018.07.015. Epub 2018 Jul 23.

PMID:
30055825
20.

Docetaxel, cisplatin, and fluorouracil chemotherapy for metastatic or unresectable locally recurrent anal squamous cell carcinoma (Epitopes-HPV02): a multicentre, single-arm, phase 2 study.

Kim S, François E, André T, Samalin E, Jary M, El Hajbi F, Baba-Hamed N, Pernot S, Kaminsky MC, Bouché O, Desrame J, Zoubir M, Ghiringhelli F, Parzy A, De La Fouchardiere C, Smith D, Deberne M, Spehner L, Badet N, Adotevi O, Anota A, Meurisse A, Vernerey D, Taieb J, Vendrely V, Buecher B, Borg C.

Lancet Oncol. 2018 Aug;19(8):1094-1106. doi: 10.1016/S1470-2045(18)30321-8. Epub 2018 Jul 2.

PMID:
30042063

Supplemental Content

Loading ...
Support Center